Hox genes are evolutionarily conserved transcription factors which act to control important developmental pathways involved in morphogenesis of the embryo. Hoxa2 is expressed in the developing CNS in rhombomeres 2-7 in the presumptive hindbrain. During development Hoxa2 expression extends caudally throughout the spinal cord and persists into adulthood.</p><p> Although previous analysis of Hoxa2 expression indicates its possible role in neuronal circuit specification and/or dorsal-ventral patterning within the spinal cord, the precise genetic pathways through which Hoxa2 affects spinal cord development have not been characterized. We have used immunoprecipitation of Hoxa2-target DNA complexes from chromatin preparations of E18 mouse spinal cord and hindbrain tissue to isolate in vivo downstream target genes of Hoxa2. Seven DNA fragments were isolated, sequenced and were shown to exhibit in vitro DNA binding by Hoxa2. A search of sequence databases for the target sequences revealed that of these, two displayed high identity with novel mouse genes: toll-associated serine protease (Tasp) and the murine homolog of the human dual specificity tyrosine phosphorylation regulated kinase 4 (Dyrk4). Also, two of the isolated clones are presumably bacterial sequences containing the canonical homeodomain binding site TAAT, and the remaining three clones have not yet been mapped in the mouse genome. A potential core Hoxa2 binding motif consisting of 5' CCATCA/T 3', which is based on a previously characterized Hoxa2-Pbx consensus sequence (Lampe et al., 2004), has been identified in both the Tasp and Dyrk4 intronic elements. Both Dyrk4 and Tasp mRNA have been detected within the developing mouse from E10-18 and in the adult CNS. Analysis by RT-PCR of Tasp expression in Hoxa2-/- newborn mice hindbrain and spinal cord tissues showed an upregulation of Tasp, and transient transfection experiments indicated that Hoxa2 may act as a transcriptional repressor of Tasp through an intronic regulatory element. Transfection studies using the intronic sequence of Dyrk4 indicated that it may function as an enhancer of transcription of Dyrk4 in the presence of Hoxa2. Both Dyrk4 and Tasp belong to large protein subfamilies whose members play a role in numerous developmental pathways in several organisms. Tasp, also known as HtrA3, interacts with TGFâ signaling molecules which are known to be key regulators of development, dorsoventral patterning and are involved in various neuronal pathways. Although the function of Dyrk4 is not known, many of its family members are involved in the regulation of transcription factors and signaling molecules via phosphorylation that are involved in neuronal pathways also. Hoxa2 may act in specifying neuronal subtypes and dorsoventral patterning in the CNS through down and upregulation of its downstream targets Dyrk4 and Tasp, respectively.

Hox genes are evolutionarily conserved transcription factors which act to control important developmental pathways involved in morphogenesis of the embryo. Hoxa2 is expressed in the developing CNS in rhombomeres 2-7 in the presumptive hindbrain. During development Hoxa2 expression extends caudally throughout the spinal cord and persists into adulthood.</p><p> Although previous analysis of Hoxa2 expression indicates its possible role in neuronal circuit specification and/or dorsal-ventral patterning within the spinal cord, the precise genetic pathways through which Hoxa2 affects spinal cord development have not been characterized. We have used immunoprecipitation of Hoxa2-target DNA complexes from chromatin preparations of E18 mouse spinal cord and hindbrain tissue to isolate in vivo downstream target genes of Hoxa2. Seven DNA fragments were isolated, sequenced and were shown to exhibit in vitro DNA binding by Hoxa2. A search of sequence databases for the target sequences revealed that of these, two displayed high identity with novel mouse genes: toll-associated serine protease (Tasp) and the murine homolog of the human dual specificity tyrosine phosphorylation regulated kinase 4 (Dyrk4). Also, two of the isolated clones are presumably bacterial sequences containing the canonical homeodomain binding site TAAT, and the remaining three clones have not yet been mapped in the mouse genome. A potential core Hoxa2 binding motif consisting of 5' CCATCA/T 3', which is based on a previously characterized Hoxa2-Pbx consensus sequence (Lampe et al., 2004), has been identified in both the Tasp and Dyrk4 intronic elements. Both Dyrk4 and Tasp mRNA have been detected within the developing mouse from E10-18 and in the adult CNS. Analysis by RT-PCR of Tasp expression in Hoxa2-/- newborn mice hindbrain and spinal cord tissues showed an upregulation of Tasp, and transient transfection experiments indicated that Hoxa2 may act as a transcriptional repressor of Tasp through an intronic regulatory element. Transfection studies using the intronic sequence of Dyrk4 indicated that it may function as an enhancer of transcription of Dyrk4 in the presence of Hoxa2. Both Dyrk4 and Tasp belong to large protein subfamilies whose members play a role in numerous developmental pathways in several organisms. Tasp, also known as HtrA3, interacts with TGFâ signaling molecules which are known to be key regulators of development, dorsoventral patterning and are involved in various neuronal pathways. Although the function of Dyrk4 is not known, many of its family members are involved in the regulation of transcription factors and signaling molecules via phosphorylation that are involved in neuronal pathways also. Hoxa2 may act in specifying neuronal subtypes and dorsoventral patterning in the CNS through down and upregulation of its downstream targets Dyrk4 and Tasp, respectively.

Kaiso is a novel member of the BTB/POZ (Broad complex, Tramtrak, Bric a brac,/Pox virus and zinc finger) zinc finger family of transcriptional regulators that have many roles in development and tumorigenesis. Kaiso was first identified as a binding partner for p 120ctn, an Armadillo catenin with roles in cell adhesion and stabilization of cadherins at the cell membrane. Kaiso is both an activator and repressor of gene transcription and interacts with two distinct types of DNA sequence; a consensus Kaiso binding site (KBS) TCCTGCNA and methylated CpG dinucleotide pairs (i.e. CpGCpG). Thus far p120's nuclear role is to inhibit Kaiso-mediated regulation of its target genes. Some of the Kaiso target genes identified to date include, matrilysin, rapsyn, and MTA2. The Kaiso homologue in Xenopus laevis (frog) has also been shown to regulate the cell cycle regulator CCND 1. Sequence analysis of the human CCND1 promoter revealed several potential Kaiso binding elements including both KBS and methylatable CpGs. My research demonstrated that Kaiso binds to the CCND1 promoter in vitro and in vivo to both KBS-specific and CpG-specific regions. Furthermore, I determined that Kaiso may act as either a repressor or activator of the human CCND 1 gene depending on the cellular environment. Altogether these data support my hypothesis that Kaiso is a regulator of the CCND1 gene. Future studies looking at the significance of KBS versus CpG-binding on Kaiso's mechanism of regulation are required to determine the significance of this regulation. Furthermore, studies examining the cell cycle-dependent changes in Kaiso levels may reveal how alterations in Kaiso expression affect Kaiso target genes including CCND1. / Thesis / Master of Science (MSc)

<p> Kaiso is a unique member of the BTB/POZ (Broad complex, Tramtrak, Bric à brac,/Pox virus and zinc finger) zinc finger family of transcription factors with established roles in development and tumourigenesis. Kaiso was originally identified as a novel binding partner of the Armadillo catenin p120^ctn, a cytosolic co-factor and regulator of the cell-cell adhesion molecule and tumor suppressor E-cadherin. In addition to their roles in cell adhesion, the multifunctional Armadillo catenins also regulate gene expression, thus providing at least two mechanisms for their contribution to tumourigenesis. The discovery of a novel interaction between p120^ctn and the transcription factor Kaiso was therefore consistent with gene regulatory roles for Armadillo catenins. Interestingly, Kaiso represses transcription via a sequence-specific DNA binding site (TCCTGCnA) as well as through methylated CpG di-nucleotides, and one role of nuclear p120^ctn is to inhibit Kaiso DNA-binding and transcriptional repression. We recently identified sequence-specific Kaiso binding sites in a subset of Wnt/β-catenin/TCF tumour-associated target genes, and here we present data characterizing cyclin D1 as a putative Kaiso target gene.</p> <p> Kaiso binds the cyclin D1 promoter in vitro and in vivo, and artificial promoter assays revealed that Kaiso overexpression results in the repression of a cyclin D1 promoter luciferase reporter. Since cyclin D1 is highly amplified in ~50% of human breast tumours, and a cancer profiling array demonstrated that Kaiso is misexpressed in ~40% of human breast tumours, we hypothesized that Kaiso represses and regulates cyclin D1 expression to inhibit breast tumourigenesis. In fact, examination of Kaiso expression in human breast cell lines demonstrated that cyclin D1 mRNA levels were upregulated in Kaiso-depleted cells. My studies further revealed that methylation-dependent Kaiso-DNA binding may contribute to Kaiso's transcriptional repression of the cyclin D1 promoter. We also determined that Kaiso inhibits, while p120^ctn activates, β-catenin-mediated activation of the cyclin D1 promoter. These findings further support a role for Kaiso and p120^ctn in breast tumourigenesis via their modulation of the canonical Wnt signaling pathway which is highly implicated in human tumourigenesis. Together these findings support our hypothesis that Kaiso regulates cyclin D1 expression. However, further studies are required to elucidate the mechanism employed by Kaiso to elicit cyclin D1 repression and to examine how this activity may contribute to breast tumourigenesis.</p> / Thesis / Master of Science (MSc)

The SARS-CoV2 pandemic has demonstrated on a global scale that viral infections can be highly contagious, can evolve rapidly, and are challenging to treat. The immune system provides cells with various control mechanisms to detect and prevent the spread of viral infection and further damage to the host. However, viruses have evolved methods to evade immunity, resulting in persevered viral replication and proliferation. Chronic viral infections occur when a virus evades immunity and persists in the body for an extended period, which can lead to increasingly harmful damage to the host, including increased risk of cancer. When immunity proves insufficient, alternative methods to sense virally infected cells can allow for detection and targeted elimination of the virus, which is especially necessary in cases of chronic viral infection. In this thesis, the development and characterization of RNA-editing enzymes based on adenosine deaminase acting on RNA (ADAR) that have been engineered to activate in response to viral protease is discussed. Specifically, methods for targeting ADAR editing to specific mRNA transcripts and strategies in which the editing activity of engineered ADARs has been made conditional upon viral proteolytic activity are explored. The development of fluorescent and quantitative assays to characterize systems are described and the implementation of the system to control downstream transcriptional activity is discussed. This thesis explores establishing the viability of a viral protease sensor able to be self-contained in an RNA circuit, which in the future may provide a treatment method for patients with severe symptoms or chronic viral infection. The ability to sense virally infected cells and create a functional output in specific response to viral protease presence as a potential future treatment of chronic viral infection is explored through viral protease activation of engineered ADAR enzymes to enable editing of specific mRNA transcripts. / 2025-05-24T00:00:00Z

4 Abstract The Wnt pathway is one of the major signaling cascades contributing to multiple cellular processes during embryogenesis, and adult tissue homeostasis and regeneration. Moreover, aberrant activation of the Wnt signaling pathway is connected with development of neoplasia, notably colorectal cancer. The aim of the thesis was to identify new ways of the Wnt pathway regulation to understand better physiological as well as non-physiological mechanisms of Wnt signaling. The results are summarized in four publications. The first article deals with TROY, a member of tumor necrosis factor receptor family. We identified TROY as a Wnt target gene during our search for Wnt responsive genes in colorectal cancer cell lines. Additionally, we detected expression of Troy in tumors of two mouse models of intestinal cancer. In the healthy gut, Troy is produced in fast cycling intestinal stem cells where negatively regulates the Wnt pathway. The second study focuses on processing and posttranslational modification of murine Wnt1 and Wnt3a. Wnts are glycosylated and double acetylated by lipid adducts and our results revealed that O-linked acylation of serine is required for the subsequent S-palmitoylation of cysteine. Moreover, acylation of Wnts is connected with their signaling activity which is related to Wnt1 and...

Over the last decade there has been a great effort to annotate noncoding regions of the genome, particularly those that regulate gene expression. These regulatory elements contain binding sites for transcription factors (TF), which interact with one another and transcriptional machinery to initiate, enhance, or repress gene expression. The Encyclopedia of DNA Elements (ENCODE) consortium has generated thousands of epigenomic datasets, such as DNase-seq and ChIP-seq experiments, with the goal of defining such regions. By integrating these assays, we developed the Registry of candidate Regulatory Elements (cREs), a collection of putative regulatory regions across human and mouse. In total, we identified over 1.3M human and 400k mouse cREs each annotated with cell-type specific signatures (e.g. promoter-like, enhancer-like) in over 400 human and 100 mouse biosamples. We then demonstrated the biological utility of these regions by analyzing cell type enrichments for genetic variants reported by genome wide association studies (GWAS). To search and visualize these cREs, we developed the online database SCREEN (search candidate regulatory elements by ENCODE). After defining cREs, we next sought to determine their potential gene targets. To compare target gene prediction methods, we developed a comprehensive benchmark of enhancer-gene links by curating ChIA-PET, Hi-C and eQTL datasets. We then used this benchmark to evaluate unsupervised linking approaches such as the correlation of epigenomic signal. We determined that these methods have low overall performance and do not outperform simply selecting the closest gene. We then developed a supervised Random Forest model which had notably better performance than unsupervised methods. We demonstrated that this model can be applied across cell types and can be used to predict target genes for GWAS associated variants. Finally, we used the registry of cREs to annotate variants associated with psychiatric disorders. We found that these "psych SNPs" are enriched in cREs active in brain tissue and likely target genes involved in neural development pathways. We also demonstrated that psych SNPs overlap binding sites for TFs involved in neural and immune pathways. Finally, by identifying psych SNPs with allele imbalance in chromatin accessibility, we highlighted specific cases of psych SNPs altering TF binding motifs resulting in the disruption of TF binding. Overall, we demonstrated our collection of putative regulatory regions, the Registry of cREs, can be used to understand the potential biological function of noncoding variation and develop hypotheses for future testing.

Abstract Wnt genes encode secreted signalling molecules that control embryonic development including organogenesis, while dysregulated Wnt signalling is connected to many diseases such as cancer. Specifically, Wnts control a number of cellular processes such as proliferation, adhesion, differentiation and aging. Many Wnt proteins activate the canonical β-catenin signalling pathway that regulates transcription of a still poorly characterized set of target genes. Wnts also transduce their signaling in cells via β-catenin-independent “non-canonical” pathways, which are not well understood. In this study, Wnt-11 signalling mechanisms in a mammalian model cell line and roles of Wnt-11 in heart development were analyzed in detail. In addition the aim was to identify new Wnt target genes by direct chromatin immunoprecipitation and Affymetrix GeneChip assays in the model cells exposed to Wnt-3a. Our studies reveal that Wnt-11 signalling coordinates the activity of key cell signalling pathways, namely the canonical Wnt/β-catenin, the JNK/AP-1, the NF-κB and PI3K/Akt pathways in the CHO cells. Analysis of the Wnt-11-deficient embryos revealed a crucial role in heart organogenesis. Wnt-11 signalling coordinates cell interactions during assembly of the myocardial wall and Wnt-11 localizes the expression of N-cadherin and β-catenin to specific cellular domains in the embryonic ventricular cardiomyocytes. Collectively these studies reveal that the mammalian Wnt-11 behaves as a non-canonical Wnt and that it is a critical factor in the coordination of heart development. Specifically, it controls components of the cell adhesion machinery. Analysis of the Wnt target genes revealed a highly context-dependent profile in the Wnt-regulated genes. Several new putative target genes were discovered. Out of the candidate Wnt target genes, Disabled-2 was identified as a potential new direct target for Wnt signalling.

No description available.

Malgré de nombreux progrès réalisés dans les traitements des cancers gynécologiques, ceux-ci demeurent la principale cause de mortalité due au cancer chez la femme. Les instabilités chromosomiques et génomiques au niveau du locus 3p21.3 sont des événements fréquents liés à des cancers épithéliaux, notamment les cancers du sein et de l'ovaire. C’est dans cette région que se trouvent les gènes hyaluronidases HYAL-1, HYAL-2 et HYAL-3. HYAL-1 est particulièrement surexprimé dans plusieurs cancers, notamment, le cancer de la prostate, la vessie, le cou, la tête et le sein où il est impliqué dans la progression tumorale et les métastases. Nous avons démontré que dans le locus 3p21.3, HYAL-1 est un gène cible sélectivement réprimé par ERα et l’estrogène. L’analyse de la cohorte METABRIC a révélé une corrélation inverse significative entre l’expression du gène HYAL-1 et ERα. Nous avons identifié des sites de liaison pour ERα au niveau du locus 3p21.3, parmi eux, un ERE proximal était responsable de la répression de HYAL-1 par ERα en plus d’un site Sp-1 requis pour atteindre une répression optimale. Cette répression de HYAL-1 est accompagnée par un enrichissement de la marque répressive H3K27me3 au niveau des deux sites ERE et Sp-1. En plus de réguler l’expression de nombreux gènes, l’activité transcriptionnelle des ERs est aussi régulée par les corégulateurs qui sont recrutés sur les ERs. Nous avons identifié un nouveau partenaire d’interaction inattendu pour les ERs, soit le facteur de transcription hématopoïétique TAL1. Malgré sa réputation d’oncogène dans les leucémies lymphoblastiques aiguës des cellules T, ce facteur de transcription est un corépresseur d’ERα, dû à son effet répresseur direct sur l’activité transcriptionnelle du récepteur en réponse à l’estrogène et donc sur l’expression de ces gènes cible dans le cancer du sein. De plus, TAL1 réprime aussi l’activation d’ERα en réponse à la phosphorylation induite par la voie des MAPK/Erk. Cette répression d’ERα par TAL1 résulte en une diminution de la prolifération et la migration des cellules cancéreuses mammaires. / Despite many advances in treatment of gynecological cancers, they remain the leading cause of cancer death in women. Chromosomal and genome instabilities at the 3p21.3 locus are frequent events related to epithelial cancers, including breast and ovarian cancers. It is in this region that the hyaluronidase HYAL-1, HYAL-2 and HYAL-3 genes are found. HYAL-1 is particularly overexpressed in several cancers, including prostate, bladder, neck, head and breast cancers where it promotes tumor progression and metastasis. We demonstrate here, that in the 3p21.3 locus, HYAL-1 is a target gene selectively repressed by ERα and estrogen. Integrative data mining using METABRIC dataset revealed a significant inverse correlation between ERα and HYAL-1 gene expression in human breast tumors. We identified binding sites for ERα at the 3p21.3 locus, among which a proximal ERE responsible for repression of HYAL-1 by ERα, in addition to an Sp-1 site required to achieve optimal repression. This repression of HYAL-1 is accompanied by an enrichment of the repressive mark H3K27me3 at the two sites ERE and Sp-1. In addition to regulate the expression of many target genes, the transcriptional activity of estrogen receptors is also regulated by coregulators who are recruited on ERs. We identified a new unexpected interaction partner for ERs, the hematopoietic transcription factor TAL1. Despite its reputation as an oncogene in T-cell acute lymphoblastic leukemia, this transcription factor is an ERα-corepressor due to its direct repressive effect on the transcriptional activity of the receptor in response to estrogen and thus to expression of its target genes in breast cancer. Moreover, TAL1 also inhibits ERs activation in response to phosphorylation induced by the MAPK/Erk pathway. This repression of ERα by TAL1 results in decreased growth and migration of mammary cancer cells.